UNSPSC 51282957: Ofloxacin hydrochloride

This classification denotes a quinolone antibiotic with the molecular formula C18H20FN3O4.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I2UWV315WA. European Medicines Agency schedules ofloxacin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03494MIG. The term ofloxacin hydrochloride is a U.S. FDA designation. Most nations schedule ofloxacin hydrochloride under HS 29349990. As of Q4 2014, OFLOXACIN HYDROCHLORIDE remains the US FDA Preferred Term for this commodity.

SMILES: CC1COC2C3N1CC(C(=O)C3CC(C2N4CCN(CC4)C)F)C(=O)O.CL.

UNSPSC 51282957 Ofloxacin hydrochloride, a Commodity code, shows little relevant recent activity. The recent opportunities tagged under this code involve naloxone procurement, direct-to-manufacturer prescription programs, general medical and first aid supplies for emergency response, and multi-source generic pharmaceuticals and OTC products through a cooperative purchasing vehicle — none of which are ofloxacin-specific pharmaceutical solicitations. The mismatch suggests that the code as applied to these opportunities does not reflect the actual scope of work being purchased.

The issuing bodies pursuing pharmaceutical and medical supply procurement include county health departments, state health and human services agencies, city fire departments, and cooperative purchasing alliances spanning multiple states. When relevant activity does emerge under related codes, the geographic spread typically spans Texas, Florida, Minnesota, and Oregon, with activity driven by state health agencies and local public health infrastructure. The recent records show no focused procurement demand specifically for ofloxacin hydrochloride at the state and local level during the current review period.